UK residents warned to get serious as cases surge

▴ UK residents warned to get serious as cases surge
Rates of infection in England are replicating the strong resurgence of Covid-19 seen in France and Spain, roughly doubling every seven days, government chief medical officer said.

England is on track for about 50,000 coronavirus cases a day by mid-October and a surge in the number of deaths unless the public gets serious about preventive action, top UK advisers warned on Monday.

Rates of infection in England are replicating the strong resurgence of Covid-19 seen in France and Spain, roughly doubling every seven days, government chief medical officer Chris Whitty said.

"We are seeing a rate of increase across the great majority of the country," he told a media briefing, urging the public to respect stricter guidelines on social distancing after widely shared pictures of young travelers out in British cities.

"This is not someone else's problem. It's all of our problems."

The briefing previewed an expected announcement by Prime Minister Boris Johnson this week detailing government action to flatten the exponential coronavirus curve heading into winter when regular respiratory diseases typically spike.

Almost 42,000 people who have tested positive for Covid-19 have died in Britain, the worst from the pandemic in Europe.

After a summer lull -- when the government urged the public to frequent pubs and restaurants -- cases have been rising rapidly to reach some 6,000 daily, according to one survey by government statisticians.

Second wave

Johnson last week said Britain was already seeing a second wave of Covid-19 -- in line with parts of Europe -- and the government introduced new restrictions for millions across northwest, northern and central England.

People in England who refuse to self-isolate to stop the spread of coronavirus could face fines of up to £10,000 ($13,000, 11,000 euros) under tough new regulations.

Johnson said that from September 28, people will be legally obliged to self-isolate if they test positive or are told to by the National Health Service (NHS) tracing program.

Whitty said it was essential for the public to play its part in preventing the NHS from being overwhelmed in the colder months.

"We are in a bad sense turning a corner, although only relatively recently. At this point the seasons are against us," he said at the briefing, alongside chief scientific adviser Patrick Vallance.

Vallance said that on current trends, the daily count of cases will reach about 50,000 on October 13, and a month later exceeds 200 deaths every day.

Whitty said "science in due course will ride to our rescue" with a successful vaccine but over the next six months, "if we don't change course, the virus will take off".

Alignment

The UK government in London controls health policy for England but the sector is a devolved issue for the administrations in Scotland, Wales, and Northern Ireland.

That has led to differing approaches to tackling the virus. Scotland's First Minister Nicola Sturgeon said she hoped for "four-nation alignment" on the next steps.

But she told a daily briefing in Edinburgh that "if necessary, it will have to happen without that".

The government in Cardiff meanwhile announced that three more areas of south Wales would be placed under local lockdown because of a rise in coronavirus cases.

Johnson was Monday holding talks with Sturgeon and the leaders of Wales and Northern Ireland, his spokesman said, following a weekend of meetings with his cabinet along with Whitty and Vallance.

The government says it prefers to avoid the kind of nationwide lockdown imposed in March but is ready to do so if required.

A further meeting is planned on Tuesday of the government's emergency response cell, Johnson's spokesman said, adding: "If further measures are needed, we won't hesitate to take them."

Tags : #UK #Cases #Surge #COVID-19 #2ndwave

Related Stories

02 Aug

Sweet Poison: Heavy Metal Contamination in Chocolate

While chocolates and cocoa-based products are generally safe to consume in moderation, it is essential to be aware of the potential risks associated with heavy metal contamination.

View
18 Mar

FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation Therapy

Lupin Limited's FDA approval for its generic Varenicline tablets marks a significant milestone in the field of smoking cessation therapy.

View
17 Nov

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need for broader insurance coverage to ensure accessibility for a larger population.

View
16 Nov

Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India Launch

As Valneva works towards making this groundbreaking vaccine available in India, the collaboration with CEPI and Instituto Butantan underlines the global effort to address infectious diseases. The upcoming regulatory interactions with DCGI will shed light on the timeline for Ixchiq's launch in India.

View
11 Nov

Historic Breakthrough: FDA Grants Accelerated Approval for Valneva’s Ixchiq - The First Chikungunya Vaccine

As the vaccine moves towards global markets, its impact on public health is poised to be substantial. The ongoing commitment to safety studies and pediatric evaluations reflects a dedication to comprehensive healthcare solutions. The pharmaceutical landscape is witnessing a transformative moment, and Ixchiq stands at the forefront of this medical breakthrough.

View
03 Nov

A New Hope for Sickle Cell Patients: Groundbreaking Gene Therapy Under FDA Review

Unlike current treatments that include drugs, blood transfusions, and bone marrow transplants, exa-cel aims to provide a one-time, DNA-altering solution. By modifying the patient's blood cells, the therapy targets the root cause of the disease, promoting the production of healthy haemoglobin.

View
23 Oct

Indian Medtech Startup Sigtuple Receives U.S. FDA approval; becomes India's 1st company in this space to earn the clearance

For all haematological disorders like blood cancers, infections, anaemia & allergies, the microscopic examination of the peripheral blood smear (PBS) is the gold standard test, but microscopy today is predominantly a manual process - necessitating a highly skilled pathologist to be present on-site.

View
06 Oct

Safety Concerns Arise: FDA Investigates Probiotic-Related Infant Death

Probiotics are live microorganisms believed to enhance health when consumed adequately, while they offer potential health benefits, this incident highlights the importance of careful consideration, especially in vulnerable populations like preterm infants.

View
05 Aug

FDA Approves Groundbreaking Postpartum Depression Oral Pill - Zurzuvae (Zuranolone)

Postpartum depression (PPD) affects countless new mothers worldwide, casting a shadow over what should be a joyful time in their lives. For years, healthcare professionals have been searching for an effective treatment for this debilitating condition. In a momentous development, the U.S. Food and Drug Administration (FDA) has recently approved the first-ever postpartum depression oral pill, Zurzuvae (Zuranolone).

View
23 Feb

4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029

Latest Pharma news

View

-Advertisements-




Trending Now

Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025
Research identifies causes of catastrophic floodingMarch 28, 2025
Why a Few Extra Inches Around Your Waist Could Cost You Your LifeMarch 28, 2025
Young IT Professional Answers Call To Be Stem Cell DonorMarch 28, 2025
5 Hidden Signs of Nutrient Deficiency You Shouldn’t IgnoreMarch 28, 2025